Submit
Search
Submit
Menu

  • Information

  • References

  • Contents

  • [1]A. I. Tauber: Metchnikoff and the phagocytosis theory. Nat Rev Mol Cell Biol 4, 897-901 (2003)

  • [2]A. Mantovani, M. A. Cassatella, C. Costantini and S. Jaillon: Neutrophils in the activation and regulation of innate and adaptive immunity. Nat Rev Immunol 11, 519-31 (2011)

  • [3]B. Amulic, C. Cazalet, G. L. Hayes, K. D. Metzler and A. Zychlinsky: Neutrophil function: from mechanisms to disease. Annu Rev Immunol 30, 459-89 (2012)

  • [4]E. Kolaczkowska and P. Kubes: Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol 13, 159-75 (2013)

  • [5]V. Kumar and A. Sharma: Neutrophils: Cinderella of innate immune system. Int Immunopharmacol 10, 1325-34 (2010)

  • [6]A. W. Segal: How neutrophils kill microbes. Annu Rev Immunol 23, 197-223 (2005)

  • [7]V. Brinkmann and A. Zychlinsky: Neutrophil extracellular traps: is immunity the second function of chromatin? J Cell Biol 198, 773-83 (2012)

  • [8]J. Bux and U. J. Sachs: The pathogenesis of transfusion-related acute lung injury (TRALI). Br J Haematol 136, 788-99 (2007)

  • [9]C. Guichard, E. Pedruzzi, C. Dewas, M. Fay, C. Pouzet, M. Bens, A. Vandewalle, E. Ogier-Denis, M. A. Gougerot-Pocidalo and C. Elbim: Interleukin-8-induced priming of neutrophil oxidative burst requires sequential recruitment of NADPH oxidase components into lipid rafts. J Biol Chem 280, 37021-32 (2005)

  • [10]M. Hurtado-Nedelec, K. Makni-Maalej, M. A. Gougerot-Pocidalo, P. M. Dang and J. El-Benna: Assessment of priming of the human neutrophil respiratory burst. Methods Mol Biol 1124, 405-12 (2014)

  • [11]J. C. Eun, E. E. Moore, A. Banerjee, M. R. Kelher, S. Y. Khan, D. J. Elzi, N. J. McLaughlin and C. C. Silliman: Leukotriene b4 and its metabolites prime the neutrophil oxidase and induce proinflammatory activation of human pulmonary microvascular endothelial cells. Shock 35, 240-4 (2011)

  • [12]E. Sapey and R. A. Stockley: Red, amber and green: the role of the lung in de-priming active systemic neutrophils. Thorax 69, 606-8 (2014)

  • [13]F. Boulay, M. Tardif, L. Brouchon and P. Vignais: Synthesis and use of a novel N-formyl peptide derivative to isolate a human N-formyl peptide receptor cDNA. Biochem Biophys Res Commun 168, 1103-9 (1990)

  • [14]H. Shen, D. Kreisel and D. R. Goldstein: Processes of sterile inflammation. J Immunol 191, 2857-63 (2013)

  • [15]P. Matzinger: Tolerance, danger, and the extended family. Annu Rev Immunol 12, 991-1045 (1994)

  • [16]J. Hazeldine, P. Hampson and J. M. Lord: The impact of trauma on neutrophil function. Injury 45, 1824-33 (2014)

  • [17]I. Migeotte, D. Communi and M. Parmentier: Formyl peptide receptors: a promiscuous subfamily of G protein-coupled receptors controlling immune responses. Cytokine Growth Factor Rev 17, 501-19 (2006)

  • [18]E. Schiffmann, H. V. Showell, B. A. Corcoran, P. A. Ward, E. Smith and E. L. Becker: The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli. J Immunol 114, 1831-7 (1975)

  • [19]H. Carp: Mitochondrial N-formylmethionyl proteins as chemoattractants for neutrophils. J Exp Med 155, 264-75 (1982)

  • [20]D. A. Dorward, C. D. Lucas, G. B. Chapman, C. Haslett, K. Dhaliwal and A. G. Rossi: The Role of Formylated Peptides and Formyl Peptide Receptor 1 in Governing Neutrophil Function during Acute Inflammation. Am J Pathol 185, 1172-1184 (2015)

  • [21]H. Fu, J. Karlsson, J. Bylund, C. Movitz, A. Karlsson and C. Dahlgren: Ligand recognition and activation of formyl peptide receptors in neutrophils. J Leukoc Biol 79, 247-56 (2006)

  • [22]F. Boulay, M. Tardif, L. Brouchon and P. Vignais: The human N-formylpeptide receptor. Characterization of two cDNA isolates and evidence for a new subfamily of G-protein-coupled receptors. Biochemistry 29, 11123-33 (1990)

  • [23]R. D. Ye, S. L. Cavanagh, O. Quehenberger, E. R. Prossnitz and C. G. Cochrane: Isolation of a cDNA that encodes a novel granulocyte N-formyl peptide receptor. Biochem Biophys Res Commun 184, 582-9 (1992)

  • [24]R. D. Ye, F. Boulay, J. M. Wang, C. Dahlgren, C. Gerard, M. Parmentier, C. N. Serhan and P. M. Murphy: International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev 61, 119-61 (2009)

  • [25]F. N. Gavins: Are formyl peptide receptors novel targets for therapeutic intervention in ischaemia-reperfusion injury? Trends Pharmacol Sci 31, 266-76 (2010)

  • [26]B. McDonald, K. Pittman, G. B. Menezes, S. A. Hirota, I. Slaba, C. C. Waterhouse, P. L. Beck, D. A. Muruve and P. Kubes: Intravascular danger signals guide neutrophils to sites of sterile inflammation. Science 330, 362-6 (2010)

  • [27]G. B. Segel, M. W. Halterman and M. A. Lichtman: The paradox of the neutrophil’s role in tissue injury. J Leukoc Biol 89, 359-72 (2011)

  • [28]J. Hazeldine, P. Hampson, F. A. Opoku, M. Foster and J. M. Lord: N-Formyl peptides drive mitochondrial damage associated molecular pattern induced neutrophil activation through ERK1/2 and P38 MAP kinase signalling pathways. Injury 46, 975-84 (2015)

  • [29]Q. Zhang, M. Raoof, Y. Chen, Y. Sumi, T. Sursal, W. Junger, K. Brohi, K. Itagaki and C. J. Hauser: Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464, 104-7 (2010)

  • [30]J. Huang, K. Chen, W. Gong, N. M. Dunlop, O. M. Howard, X. Bian, Y. Gao and J. M. Wang: Regulation of the leucocyte chemoattractant receptor FPR in glioblastoma cells by cell differentiation. Carcinogenesis 30, 348-55 (2009)

  • [31]T. Y. Cheng, M. S. Wu, J. T. Lin, M. T. Lin, C. T. Shun, K. T. Hua and M. L. Kuo: Formyl Peptide receptor 1 expression is associated with tumor progression and survival in gastric cancer. Anticancer Res 34, 2223-9 (2014)

  • [32]F. Cattaneo, M. Parisi and R. Ammendola: Distinct signaling cascades elicited by different formyl peptide receptor 2 (FPR2) agonists. Int J Mol Sci 14, 7193-230 (2013)

  • [33]W. Kao, R. Gu, Y. Jia, X. Wei, H. Fan, J. Harris, Z. Zhang, J. Quinn, E. F. Morand and Y. H. Yang: A formyl peptide receptor agonist suppresses inflammation and bone damage in arthritis. Br J Pharmacol 171, 4087-96 (2014)

  • [34]H. Y. Lee, S. D. Kim, S. H. Baek, J. H. Choi and Y. S. Bae: Role of formyl peptide receptor 2 on the serum amyloid A-induced macrophage foam cell formation. Biochem Biophys Res Commun 433, 255-9 (2013)

  • [35]C. N. Serhan, N. Chiang and T. E. Van Dyke: Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 8, 349-61 (2008)

  • [36]D. El Kebir, L. Jozsef, T. Khreiss, W. Pan, N. A. Petasis, C. N. Serhan and J. G. Filep: Aspirin-triggered lipoxins override the apoptosis-delaying action of serum amyloid A in human neutrophils: a novel mechanism for resolution of inflammation. J Immunol 179, 616-22 (2007)

  • [37]J. P. Vago, C. R. Nogueira, L. P. Tavares, F. M. Soriani, F. Lopes, R. C. Russo, V. Pinho, M. M. Teixeira and L. P. Sousa: Annexin A1 modulates natural and glucocorticoid-induced resolution of inflammation by enhancing neutrophil apoptosis. J Leukoc Biol 92, 249-58 (2012)

  • [38]S. Bozinovski, M. Uddin, R. Vlahos, M. Thompson, J. L. McQualter, A. S. Merritt, P. A. Wark, A. Hutchinson, L. B. Irving, B. D. Levy and G. P. Anderson: Serum amyloid A opposes lipoxin A(4) to mediate glucocorticoid refractory lung inflammation in chronic obstructive pulmonary disease. Proc Natl Acad Sci U S A 109, 935-40 (2012)

  • [39]T. Devosse, R. Dutoit, I. Migeotte, P. De Nadai, V. Imbault, D. Communi, I. Salmon and M. Parmentier: Processing of HEBP1 by cathepsin D gives rise to F2L, the agonist of formyl peptide receptor 3. J Immunol 187, 1475-85 (2011)

  • [40]T. Devosse, A. Guillabert, N. D’Haene, A. Berton, P. De Nadai, S. Noel, M. Brait, J. D. Franssen, S. Sozzani, I. Salmon and M. Parmentier: Formyl peptide receptor-like 2 is expressed and functional in plasmacytoid dendritic cells, tissue-specific macrophage subpopulations, and eosinophils. J Immunol 182, 4974-84 (2009)

  • [41]E. Schiffmann, B. A. Corcoran and S. M. Wahl: N-formylmethionyl peptides as chemoattractants for leucocytes. Proc Natl Acad Sci U S A 72, 1059-62 (1975)

  • [42]W. A. Marasco, S. H. Phan, H. Krutzsch, H. J. Showell, D. E. Feltner, R. Nairn, E. L. Becker and P. A. Ward: Purification and identification of formyl-methionyl-leucyl-phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J Biol Chem 259, 5430-9 (1984)

  • [43]D. Feng, J. A. Nagy, K. Pyne, H. F. Dvorak and A. M. Dvorak: Neutrophils emigrate from venules by a transendothelial cell pathway in response to FMLP. J Exp Med 187, 903-15 (1998)

  • [44]M. J. Rabiet, E. Huet and F. Boulay: Human mitochondria-derived N-formylated peptides are novel agonists equally active on FPR and FPRL1, while Listeria monocytogenes-derived peptides preferentially activate FPR. Eur J Immunol 35, 2486-95 (2005)

  • [45]E. D. Crouser, G. Shao, M. W. Julian, J. E. Macre, G. S. Shadel, S. Tridandapani, Q. Huang and M. D. Wewers: Monocyte activation by necrotic cells is promoted by mitochondrial proteins and formyl peptide receptors. Crit Care Med 37, 2000-9 (2009)

  • [46]M. Raoof, Q. Zhang, K. Itagaki and C. J. Hauser: Mitochondrial peptides are potent immune activators that activate human neutrophils via FPR-1. J Trauma 68, 1328-32; discussion 1332-4 (2010)

  • [47]Y. Le, W. Gong, B. Li, N. M. Dunlop, W. Shen, S. B. Su, R. D. Ye and J. M. Wang: Utilization of two seven-transmembrane, G protein-coupled receptors, formyl peptide receptor-like 1 and formyl peptide receptor, by the synthetic hexapeptide WKYMVm for human phagocyte activation. J Immunol 163, 6777-84 (1999)

  • [48]J. Bylund, M. Samuelsson, L. V. Collins and A. Karlsson: NADPH-oxidase activation in murine neutrophils via formyl peptide receptors. Exp Cell Res 282, 70-7 (2003)

  • [49]E. Fabbri, S. Spisani, L. Barbin, C. Biondi, M. Buzzi, S. Traniello, G. P. Zecchini and M. E. Ferretti: Studies on fMLP-receptor interaction and signal transduction pathway by means of fMLP-OMe selective analogues. Cell Signal 12, 391-8 (2000)

  • [50]G. Cavicchioni, M. Turchetti and S. Spisani: Biological variation responses in fMLP-OMe analogs, introducing bulky protecting groups on the side-chain of hydrophilic residues at position 2. J Pept Res 60, 223-31 (2002)

  • [51]G. Cavicchioni, M. Turchetti, K. Varani, S. Falzarano and S. Spisani: Properties of a novel chemotactic esapeptide, an analogue of the prototypical N-formylmethionyl peptide. Bioorg Chem 31, 322-30 (2003)

  • [52]S. B. Su, W. H. Gong, J. L. Gao, W. P. Shen, M. C. Grimm, X. Deng, P. M. Murphy, J. J. Oppenheim and J. M. Wang: T20/DP178, an ectodomain peptide of human immunodeficiency virus type 1 gp41, is an activator of human phagocyte N-formyl peptide receptor. Blood 93, 3885-92 (1999)

  • [53]L. Bellner, F. Thoren, E. Nygren, J. A. Liljeqvist, A. Karlsson and K. Eriksson: A proinflammatory peptide from herpes simplex virus type2 glycoprotein G affects neutrophil, monocyte, and NK cell functions. J Immunol 174, 2235-41 (2005)

  • [54]R. Sun, P. Iribarren, N. Zhang, Y. Zhou, W. Gong, E. H. Cho, S. Lockett, O. Chertov, F. Bednar, T. J. Rogers, J. J. Oppenheim and J. M. Wang: Identification of neutrophil granule protein cathepsin G as a novel chemotactic agonist for the G protein-coupled formyl peptide receptor. J Immunol 173, 428-36 (2004)

  • [55]A. Walther, K. Riehemann and V. Gerke: A novel ligand of the formyl peptide receptor: annexin I regulates neutrophil extravasation by interacting with the FPR. Mol Cell 5, 831-40 (2000)

  • [56]F. N. Gavins, S. Yona, A. M. Kamal, R. J. Flower and M. Perretti: Leucocyte antiadhesive actions of annexin 1: ALXR-and FPR-related anti-inflammatory mechanisms. Blood 101, 4140-7 (2003)

  • [57]J. Karlsson, H. Fu, F. Boulay, C. Dahlgren, K. Hellstrand and C. Movitz: Neutrophil NADPH-oxidase activation by an annexin AI peptide is transduced by the formyl peptide receptor (FPR), whereas an inhibitory signal is generated independently of the FPR family receptors. J Leukoc Biol 78, 762-71 (2005)

  • [58]Y. Yang, Y. Liu, X. Yao, Y. Ping, T. Jiang, Q. Liu, S. Xu, J. Huang, H. Mou, W. Gong, K. Chen, X. Bian and J. M. Wang: Annexin 1 released by necrotic human glioblastoma cells stimulates tumor cell growth through the formyl peptide receptor 1. Am J Pathol 179, 1504-12 (2011)

  • [59]G. Leoni, A. Alam, P. A. Neumann, J. D. Lambeth, G. Cheng, J. McCoy, R. S. Hilgarth, K. Kundu, N. Murthy, D. Kusters, C. Reutelingsperger, M. Perretti, C. A. Parkos, A. S. Neish and A. Nusrat: Annexin A1, formyl peptide receptor, and NOX1 orchestrate epithelial repair. J Clin Invest 123, 443-54 (2013)

  • [60]Y. Le, P. M. Murphy and J. M. Wang: Formyl-peptide receptors revisited. Trends Immunol 23, 541-8 (2002)

  • [61]E. Hirsch, V. L. Katanaev, C. Garlanda, O. Azzolino, L. Pirola, L. Silengo, S. Sozzani, A. Mantovani, F. Altruda and M. P. Wymann: Central role for G protein-coupled phosphoinositide 3-kinase gamma in inflammation. Science 287, 1049-53 (2000)

  • [62]R. Selvatici, S. Falzarano, A. Mollica and S. Spisani: Signal transduction pathways triggered by selective formylpeptide analogues in human neutrophils. Eur J Pharmacol 534, 1-11 (2006)

  • [63]T. L. Hwang, G. L. Li, Y. H. Lan, Y. C. Chia, P. W. Hsieh, Y. H. Wu and Y. C. Wu: Potent inhibition of superoxide anion production in activated human neutrophils by isopedicin, a bioactive component of the Chinese medicinal herb Fissistigma oldhamii. Free Radic Biol Med 46, 520-8 (2009)

  • [64]T. L. Hwang, Y. C. Su, H. L. Chang, Y. L. Leu, P. J. Chung, L. M. Kuo and Y. J. Chang: Suppression of superoxide anion and elastase release by C18 unsaturated fatty acids in human neutrophils. J Lipid Res 50, 1395-408 (2009)

  • [65]H. Chong, J. Lee and K. L. Guan: Positive and negative regulation of Raf kinase activity and function by phosphorylation. EMBO J 20, 3716-27 (2001)

  • [66]J. S. Sebolt-Leopold and R. Herrera: Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat Rev Cancer 4, 937-47 (2004)

  • [67]R. Schreck and U. R. Rapp: Raf kinases: oncogenesis and drug discovery. Int J Cancer 119, 2261-71 (2006)

  • [68]D. Okutani, M. Lodyga, B. Han and M. Liu: Src protein tyrosine kinase family and acute inflammatory responses. Am J Physiol Lung Cell Mol Physiol 291, L129-41 (2006)

  • [69]A. Ptasznik, A. Traynor-Kaplan and G. M. Bokoch: G protein-coupled chemoattractant receptors regulate Lyn tyrosine kinase Shc adapter protein signaling complexes. J Biol Chem 270, 19969-73 (1995)

  • [70]T. Saito and M. Gale, Jr.: Principles of intracellular viral recognition. Curr Opin Immunol 19, 17-23 (2007)

  • [71]K. L. Rock, E. Latz, F. Ontiveros and H. Kono: The sterile inflammatory response. Annu Rev Immunol 28, 321-42 (2010)

  • [72]J. L. Gao, E. J. Lee and P. M. Murphy: Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor. J Exp Med 189, 657-62 (1999)

  • [73]M. Liu, K. Chen, T. Yoshimura, Y. Liu, W. Gong, A. Wang, J. L. Gao, P. M. Murphy and J. M. Wang: Formylpeptide receptors are critical for rapid neutrophil mobilization in host defense against Listeria monocytogenes. Sci Rep 2, 786 (2012)

  • [74]S. Oldekamp, S. Pscheidl, E. Kress, O. Soehnlein, S. Jansen, T. Pufe, J. M. Wang, S. C. Tauber and L. O. Brandenburg: Lack of formyl peptide receptor 1 and 2 leads to more severe inflammation and higher mortality in mice with of pneumococcal meningitis. Immunology 143, 447-61 (2014)

  • [75]P. Mandal, M. Novotny and T. A. Hamilton: Lipopolysaccharide induces formyl peptide receptor 1 gene expression in macrophages and neutrophils via transcriptional and posttranscriptional mechanisms. J Immunol 175, 6085-91 (2005)

  • [76]J. Grommes, M. Drechsler and O. Soehnlein: CCR5 and FPR1 mediate neutrophil recruitment in endotoxin-induced lung injury. J Innate Immun 6, 111-6 (2014)

  • [77]L. Galluzzi, O. Kepp and G. Kroemer: Mitochondria: master regulators of danger signalling. Nat Rev Mol Cell Biol 13, 780-8 (2012)

  • [78]D. V. Krysko, P. Agostinis, O. Krysko, A. D. Garg, C. Bachert, B. N. Lambrecht and P. Vandenabeele: Emerging role of damage-associated molecular patterns derived from mitochondria in inflammation. Trends Immunol 32, 157-64 (2011)

  • [79]P. Kubes and W. Z. Mehal: Sterile inflammation in the liver. Gastroenterology 143, 1158-72 (2012)

  • [80]C. J. Hauser, T. Sursal, E. K. Rodriguez, P. T. Appleton, Q. Zhang and K. Itagaki: Mitochondrial damage associated molecular patterns from femoral reamings activate neutrophils through formyl peptide receptors and P44/42 MAP kinase. J Orthop Trauma 24, 534-8 (2010)

  • [81]P. E. Marques, S. S. Amaral, D. A. Pires, L. L. Nogueira, F. M. Soriani, B. H. Lima, G. A. Lopes, R. C. Russo, T. V. Avila, J. G. Melgaco, A. G. Oliveira, M. A. Pinto, C. X. Lima, A. M. De Paula, D. C. Cara, M. F. Leite, M. M. Teixeira and G. B. Menezes: Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure. Hepatology 56, 1971-82 (2012)

  • [82]S. Bao, Q. Wu, R. E. McLendon, Y. Hao, Q. Shi, A. B. Hjelmeland, M. W. Dewhirst, D. D. Bigner and J. N. Rich: Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444, 756-60 (2006)

  • [83]Y. Le, J. Hu, W. Gong, W. Shen, B. Li, N. M. Dunlop, D. O. Halverson, D. G. Blair and J. M. Wang: Expression of functional formyl peptide receptors by human astrocytoma cell lines. J Neuroimmunol 111, 102-8 (2000)

  • [84]J. Margareto, O. Leis, E. Larrarte, M. A. Idoate, A. Carrasco and J. V. Lafuente: Gene expression profiling of human gliomas reveals differences between GBM and LGA related to energy metabolism and notch signaling pathways. J Mol Neurosci 32, 53-63 (2007)

  • [85]Y. Zhou, X. Bian, Y. Le, W. Gong, J. Hu, X. Zhang, L. Wang, P. Iribarren, R. Salcedo, O. M. Howard, W. Farrar and J. M. Wang: Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. J Natl Cancer Inst 97, 823-35 (2005)

  • [86]J. Huang, K. Chen, J. Chen, W. Gong, N. M. Dunlop, O. M. Howard, Y. Gao, X. W. Bian and J. M. Wang: The G-protein-coupled formylpeptide receptor FPR confers a more invasive phenotype on human glioblastoma cells. Br J Cancer 102, 1052-60 (2010)

  • [87]X. H. Yao, Y. F. Ping, J. H. Chen, D. L. Chen, C. P. Xu, J. Zheng, J. M. Wang and X. W. Bian: Production of angiogenic factors by human glioblastoma cells following activation of the G-protein coupled formylpeptide receptor FPR. J Neurooncol 86, 47-53 (2008)

  • [88]X. H. Yao, Y. F. Ping, J. H. Chen, C. P. Xu, D. L. Chen, R. Zhang, J. M. Wang and X. W. Bian: Glioblastoma stem cells produce vascular endothelial growth factor by activation of a G-protein coupled formylpeptide receptor FPR. J Pathol 215, 369-76 (2008)

  • [89]J. Huang, J. Hu, X. Bian, K. Chen, W. Gong, N. M. Dunlop, O. M. Howard and J. M. Wang: Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells. Cancer Res 67, 5906-13 (2007)

  • [90]N. Prevete, F. Liotti, C. Visciano, G. Marone, R. M. Melillo and A. de Paulis: The formyl peptide receptor 1 exerts a tumor suppressor function in human gastric cancer by inhibiting angiogenesis. Oncogene (2014)

  • [91]S. Bozinovski, D. Anthony, G. P. Anderson, L. B. Irving, B. D. Levy and R. Vlahos: Treating neutrophilic inflammation in COPD by targeting ALX/FPR2 resolution pathways. Pharmacol Ther 140, 280-9 (2013)

  • [92]R. A. Stockley, R. A. Grant, C. G. Llewellyn-Jones, S. L. Hill and D. Burnett: Neutrophil formyl-peptide receptors. Relationship to peptide-induced responses and emphysema. Am J Respir Crit Care Med 149, 464-8 (1994)

  • [93]S. Cardini, J. Dalli, S. Fineschi, M. Perretti, G. Lungarella and M. Lucattelli: Genetic ablation of the fpr1 gene confers protection from smoking-induced lung emphysema in mice. Am J Respir Cell Mol Biol 47, 332-9 (2012)

  • [94]M. I. Ledesma de Paolo, P. Celener Gravelle, J. A. De Paula, M. T. Panzita, J. C. Bandi and L. Bustos Fernandez: Stimulation of inflammatory mediators secretion by chemotactic peptides in rat colitis model. Acta Gastroenterol Latinoam 26, 23-30 (1996)

  • [95]J. F. Chester, J. S. Ross, R. A. Malt and S. A. Weitzman: Acute colitis produced by chemotactic peptides in rats and mice. Am J Pathol 121, 284-90 (1985)

  • [96]E. L. Becker, F. A. Forouhar, M. L. Grunnet, F. Boulay, M. Tardif, B. J. Bormann, D. Sodja, R. D. Ye, J. R. Woska, Jr. and P. M. Murphy: Broad immunocytochemical localization of the formylpeptide receptor in human organs, tissues, and cells. Cell Tissue Res 292, 129-35 (1998)

  • [97]C. C. Wentworth, R. M. Jones, Y. M. Kwon, A. Nusrat and A. S. Neish: Commensal-epithelial signaling mediated via formyl peptide receptors. Am J Pathol 177, 2782-90 (2010)

  • [98]B. A. Babbin, W. Y. Lee, C. A. Parkos, L. M. Winfree, A. Akyildiz, M. Perretti and A. Nusrat: Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J Biol Chem 281, 19588-99 (2006)

  • [99]B. A. Babbin, A. J. Jesaitis, A. I. Ivanov, D. Kelly, M. Laukoetter, P. Nava, C. A. Parkos and A. Nusrat: Formyl peptide receptor-1 activation enhances intestinal epithelial cell restitution through phosphatidylinositol 3-kinase-dependent activation of Rac1 and Cdc42. J Immunol 179, 8112-21 (2007)

  • [100]A. Alam, G. Leoni, C. C. Wentworth, J. M. Kwal, H. Wu, C. S. Ardita, P. A. Swanson, J. D. Lambeth, R. M. Jones, A. Nusrat and A. S. Neish: Redox signaling regulates commensal-mediated mucosal homeostasis and restitution and requires formyl peptide receptor 1. Mucosal Immunol 7, 645-55 (2014)

  • [101]S. M. Farooq and A. W. Stadnyk: Neutrophil infiltration of the colon is independent of the FPR1 yet FPR1 deficient mice show differential susceptibilities to acute versus chronic induced colitis. Dig Dis Sci 57, 1802-12 (2012)

  • [102]G. C. Armitage: Periodontal diagnoses and classification of periodontal diseases. Periodontol 200034, 9-21 (2004)

  • [103]G. Nussbaum and L. Shapira: How has neutrophil research improved our understanding of periodontal pathogenesis? J Clin Periodontol 38 Suppl 11, 49-59 (2011)

  • [104]M. I. Ryder: Comparison of neutrophil functions in aggressive and chronic periodontitis. Periodontol 2000 53, 124-37 (2010)

  • [105]G. Fredman, S. F. Oh, S. Ayilavarapu, H. Hasturk, C. N. Serhan and T. E. Van Dyke: Impaired phagocytosis in localized aggressive periodontitis: rescue by Resolvin E1. PLoS One 6, e24422 (2011)

  • [106]H. Meng, L. Xu, Q. Li, J. Han and Y. Zhao: Determinants of host susceptibility in aggressive periodontitis. Periodontol 2000 43, 133-59 (2007)

  • [107]K. Shibata, M. L. Warbington, B. J. Gordon, H. Kurihara and T. E. Van Dyke: Defective calcium influx factor activity in neutrophils from patients with localized juvenile periodontitis. J Periodontol 71, 797-802 (2000)

  • [108]H. M. Roberts, M. R. Ling, R. Insall, G. Kalna, J. Spengler, M. M. Grant and I. L. Chapple: Impaired neutrophil directional chemotactic accuracy in chronic periodontitis patients. J Clin Periodontol 42, 1-11 (2015)

  • [109]P. Maney, P. Emecen, J. S. Mills and J. D. Walters: Neutrophil formylpeptide receptor single nucleotide polymorphism 348T>C in aggressive periodontitis. J Periodontol 80, 492-8 (2009)

  • [110]P. Maney and J. D. Walters: Formylpeptide receptor single nucleotide polymorphism 348T>C and its relationship to polymorphonuclear leucocyte chemotaxis in aggressive periodontitis. J Periodontol 80, 1498-505 (2009)

  • [111]A. R. Vieira and J. M. Albandar: Role of genetic factors in the pathogenesis of aggressive periodontitis. Periodontol 2000 65, 92-106 (2014)

  • [112]H. Yoshie, T. Kobayashi, H. Tai and J. C. Galicia: The role of genetic polymorphisms in periodontitis. Periodontol 2000 43, 102-32 (2007)

  • [113]Z. Wang and T. Nakayama: Inflammation, a link between obesity and cardiovascular disease. Mediators Inflamm 2010, 535918 (2010)

  • [114]M. Y. Donath and S. E. Shoelson: Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11, 98-107 (2011)

  • [115]H. Cevik-Aras, C. Kalderen, A. Jenmalm Jensen, T. Oprea, C. Dahlgren and H. Forsman: Anon-peptide receptor inhibitor with selectivity for one of the neutrophil formyl peptide receptors, FPR 1. Biochem Pharmacol 83, 1655-62 (2012)

Article Metrics

  • Information

  • Download

  • Contents

Frontiers in Bioscience-Elite (FBE) is published by IMR Press from Volume 13 Issue 2 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

1 Jun 2016Review

The potential impacts of formyl peptide receptor 1 in inflammatory diseases

Shun-Chin Yang 1,2,3, Tsong-Long Hwang 3,4,5,*
Affiliations
Article Info

1 Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan

2 Department of Anesthesiology, Taipei Veterans General Hospital and National Yang-Ming University, Taipei, Taiwan

3 Graduate Institute of Natural Products, School of Traditional Medicine, College of Medicine, and Chinese Herbal Medicine Research Team, Healthy Aging Research Center, Chang Gung University, Taoyuan, Taiwan

4 Research Center for Industry of Human Ecology and Graduate Institute of Health Industry Technology, Chang Gung University of Science and Technology, Taoyuan 333, Taiwan

5 Immunology Consortium, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan

*Author to whom correspondence should be addressed.

Abstract

Neutrophils play a critical role in acute and chronic inflammatory diseases. N-formyl peptides, which originate from bacterial peptides or mitochondrial proteins bind with a high binding affinity to formyl peptide receptor 1 (FPR1). N-formyl peptide-FPR1 is involved in the pathogenesis of sterile and infectious inflammatory processes and causes phagocytosis of pathogens or injured cells by neutrophils. Excessive activation of neutrophils by binding of N-formyl peptides is associated with tissue injury requiring drugs that block FPR1-dependent signaling. Here, we review the roles of FPR1 as a critical regulator of inflammatory processes and its involvement in pathological conditions.

Keywords

  • Formyl Peptide Receptor
  • Human Diseases
  • Review

References